Skip to main content
J

JIANGSU COWIN BIOTECH CO., LTD. — Investor Relations & Filings

Ticker · 688426 Shanghai Stock Exchange Manufacturing
Filings indexed 450 across all filing types
Latest filing 2026-04-23 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688426

About JIANGSU COWIN BIOTECH CO., LTD.

Jiangsu Cowin Biotech Co., Ltd. specializes in the development and manufacture of molecular biology reagents and kits. The company provides a comprehensive range of products including DNA and RNA extraction and purification systems, PCR and qPCR reagents, protein markers, and antibodies. Additionally, it offers solutions for next-generation sequencing (NGS) library preparation and various laboratory consumables. Serving life science research, clinical diagnostics, and pharmaceutical sectors, the company focuses on delivering reliable tools for genomic and proteomic analysis. Its portfolio supports diverse applications ranging from basic academic research to industrial biotechnology and molecular diagnostics.

Recent filings

Filing Released Lang Actions
董事、高级管理人员薪酬管理制度
Regulatory Filings
2026-04-23 Chinese
董事会审计委员会对会计师事务所履行监督职责情况的报告
Regulatory Filings
2026-04-23 Chinese
2026年度“提质增效重回报”行动方案
Regulatory Filings
2026-04-23 Chinese
2025年度内部控制评价报告
Regulatory Filings
2026-04-23 Chinese
关于2025年度计提资产减值准备的公告
Regulatory Filings
2026-04-23 Chinese
对会计师事务所履职情况评估的报告
Regulatory Filings
2026-04-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.